{"id":885245,"date":"2025-09-10T15:43:49","date_gmt":"2025-09-10T19:43:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/"},"modified":"2025-09-10T15:43:49","modified_gmt":"2025-09-10T19:43:49","slug":"alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/","title":{"rendered":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Sept.  10, 2025  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Alto Neuroscience, Inc. (NYSE: ANRO).<\/strong><\/p>\n<p>Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PIE8a3B7xRqmllJ1T-_0I-o-ryWY4bX8A2xfi2N_lYWHQlERtv5SpVubN3Ut_R5Jf4D1MVeQm5L5zWwkaZmk7XnIITOCDS7fry7Bn-MesEkKYNdfZAQ8Zvp3Ky0E8cPDHgl2_UAHsgbmZoHVGCWiRUsxSHWiuR7FAMnbMeJEOxvCWeIeGdrctP9g4maiaTc4eQehR4-kPFwp3rWnP2d_560QKTvzZM9nQIX4NiYCTi4StbIAsFfZKbHMkxDRSeZlH9Oq-imoFZ-M9pMpUALsJaErYQA9kbbhJcM2ZIvCI3tlaVZNraxrCn-_2E-lkhqp\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=166110&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive.<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (i) The Company\u2019s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100\u2019s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto\u2019s business and\/or financial prospects were overstated; and (iv) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n<p>\n        <strong>DEADLINE: September 19, 2025<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PIE8a3B7xRqmllJ1T-_0I-o-ryWY4bX8A2xfi2N_lYWHQlERtv5SpVubN3Ut_R5Jf4D1MVeQm5L5zWwkaZmk7XnIITOCDS7fry7Bn-MesEkKYNdfZAQ8Zvp3Ky0E8cPDHgl2_UAHsgbmZoHVGCWiReo9hJqtkBNTJjpUPD7KsaL8EtQ1FkYI19nQwAUwuA8NBKgX06GFzmYc7IqSzTJavr1bV4937m5L0rrwbAZPD1aFqBxavpI_ydvm_mWnTr1sspX8EeHHZ3Z6VI2Fx9FhWh4ydnttniACaerlFnV7jZf6uVaya3Cbz-C-FivnWYhX\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=166110&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of ANRO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 19, 2025. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hTsi57vAe0-AOrqzolaLjI1zn-bIGR2ZSzue31-WLcKswjRq4nGsVgE4mn5AQU2m4RgbQwZCWndcRoFYx0TXxhcIkuUPQ_2aCVqLtLZjcHY2EvFv-7SDmxJpm-Tkmhb7\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmRjYzg5NDctOGQ2My00ZjNiLWE5M2QtYWEwMTA4MjFkNGIxLTEyNzA0NjctMjAyNS0wOS0xMC1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=166110&amp;from=3 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-885245","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=166110&amp;from=3 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October &hellip; Continue reading &quot;Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T19:43:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO\",\"datePublished\":\"2025-09-10T19:43:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/\"},\"wordCount\":448,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/\",\"name\":\"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\",\"datePublished\":\"2025-09-10T19:43:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/","og_locale":"en_US","og_type":"article","og_title":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk","og_description":"NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/alto-neuroscience-inc-loss-submission-form\/?id=166110&amp;from=3 CLASS PERIOD: This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and\/or traceable to the Offering Documents issued in connection with the Company\u2019s initial public offering conducted on or about February 2, 2024; and\/or (b) Alto securities between February 2, 2024 and October &hellip; Continue reading \"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-10T19:43:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO","datePublished":"2025-09-10T19:43:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/"},"wordCount":448,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/","name":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=","datePublished":"2025-09-10T19:43:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyNjI4MiM3MTM5MDE1IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alto-neuroscience-inc-sued-for-securities-law-violations-investors-should-contact-the-gross-law-firm-before-september-19-2025-to-discuss-your-rights-anro-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alto Neuroscience, Inc. Sued for Securities Law Violations \u2013 Investors Should Contact The Gross Law Firm Before September 19, 2025 to Discuss Your Rights \u2013 ANRO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/885245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=885245"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/885245\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=885245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=885245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=885245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}